US 8,710,232 B2Granted

Imidazole derivatives used as TAFIa inhibitors

AssigneeSanofi-Aventis Deutschland GmbH

InventorsChristopher Kallus, Holger Heitsch, Andreas Lindenschmidt, Sven Grueneberg, Hauke Szillat

Life of this patent

Estimating the term…

Abstract

The present invention relates to compounds of formula (I) which are inhibitors of the activated thrombin-activatable fibrinolysis inhibitor. The compounds of formula (I) are suited for producing medicaments for the prevention and treatment of diseases accompanied by thromboses, embolisms, hypercoagulability or fibrotic changes.

Claims1

Dependent claims

The compound 3-(6-Aminopyridin-3-yl)-2-(1-cyclohexyl-1H-imidazol-4-yl)propionic acid, which corresponds to the following structure:

Dependencies are inferred from the claim text.

Facts

Application: 11/551,975Filed 23 Oct 2006 · continuation
Priority: DE 10 2004 020 18622 Apr 2004
Published: US 2007/0129341 A17 Jun 2007
Granted: 29 Apr 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07D 401/06
Containing two hetero rings: linked by a carbon chain containing only aliphatic carbon atoms
C07D 401/14
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a…:…
C07D 409/14
Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms: containing three…
C07D 417/06
Containing two hetero rings: linked by a carbon chain containing only aliphatic carbon atoms

Family

Application60/606,782Us provisional application · filed 2 Sep 2004
PCT/EP2005/003630Parent of this continuation · filed 7 Apr 2005
US 2007/0129341 A1Pre-grant publication · published 7 Jun 2007
US 8,710,232 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results